hydrocodone bitartrate · Recro Gainesville · NDA 202880

Zohydro Er

Earliest generic entry, as listed · earliest of 6 marketed strengths
12 Sep 2034

No marketed reference-listed strength; date taken from all listed strengths.

Blocked by patent: US 10092559, US 9132096, US 9452163, US 9486451, US 9713611.

Listed patents · 16 unexpired

PatentClaimsExpires
US 10092559use U-5512 Sep 2034
US 9132096product12 Sep 2034
US 9452163use U-5512 Sep 2034
US 9486451use U-5512 Sep 2034
US 9713611product, use U-5512 Sep 2034
US 10028946use U-181025 Jul 2033
US 10322120product25 Jul 2033
US 10456393use U-181025 Jul 2033
US 10722511use U-181025 Jul 2033
US 9265760use U-181025 Jul 2033
US 9326982use U-181025 Jul 2033
US 9333201use U-181025 Jul 2033
US 9339499use U-181025 Jul 2033
US 9421200use U-181025 Jul 2033
US 9433619use U-181025 Jul 2033
US 9610286use U-181025 Jul 2033

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 6

NDA · productFormStrengthListed expiry
202880 · 001 · RLD · discontinuedcapsule, extended release, oral10MG12 Sep 2034
202880 · 002 · RLD · discontinuedcapsule, extended release, oral15MG12 Sep 2034
202880 · 003 · RLD · discontinuedcapsule, extended release, oral20MG12 Sep 2034
202880 · 004 · RLD · discontinuedcapsule, extended release, oral30MG12 Sep 2034
202880 · 005 · RLD · discontinuedcapsule, extended release, oral40MG12 Sep 2034
202880 · 006 · RLD · discontinuedcapsule, extended release, oral50MG12 Sep 2034